Projected Income Statement: Genpact Limited

Forecast Balance Sheet: Genpact Limited

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 756 780 683 573 688 179 -553 -1,667
Change - 3.17% -12.44% -16.11% 20.07% -74% -408.94% -201.45%
Announcement Date 2/11/22 2/9/23 2/8/24 2/6/25 2/5/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Genpact Limited

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 53.34 50.61 55.42 82.77 78.2 103 116.6 127.6
Change - -5.11% 9.5% 49.34% -5.51% 31.67% 13.29% 9.42%
Free Cash Flow (FCF) 1 640.9 393.1 435.4 532.7 734.7 684.5 794.3 -
Change - -38.68% 10.77% 22.34% 37.92% -6.83% 16.05% -100%
Announcement Date 2/11/22 2/9/23 2/8/24 2/6/25 2/5/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Genpact Limited

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 19.19% 18.42% 18.66% 18.54% 18.86% 18.87% 19.35% 19.26%
EBIT Margin (%) 16.48% 16.43% 17.04% 17.07% 17.47% 17.68% 17.91% 18.15%
EBT Margin (%) 12.01% 10.64% 13.45% 14.2% 14.37% 14.81% 15.03% 15.23%
Net margin (%) 9.19% 8.08% 14.1% 10.78% 10.88% 11.22% 11.41% 11.66%
FCF margin (%) 15.94% 8.99% 9.73% 11.17% 14.46% 12.59% 13.62% -
FCF / Net Income (%) 173.49% 111.22% 68.97% 103.7% 132.97% 112.28% 119.39% -

Profitability

        
ROA 7.5% 7.1% 13.44% 10.49% 11.91% 10.7% 10.6% 9.66%
ROE 19.8% 18.63% 30.99% 22.15% 26.11% 24.82% 23.18% 20.49%

Financial Health

        
Leverage (Debt/EBITDA) 0.98x 0.97x 0.82x 0.65x 0.72x 0.17x - -
Debt / Free cash flow 1.18x 1.98x 1.57x 1.08x 0.94x 0.26x - -

Capital Intensity

        
CAPEX / Current Assets (%) 1.33% 1.16% 1.24% 1.74% 1.54% 1.89% 2% 2.02%
CAPEX / EBITDA (%) 6.91% 6.29% 6.63% 9.37% 8.16% 10.04% 10.34% 10.49%
CAPEX / FCF (%) 8.32% 12.88% 12.73% 15.54% 10.64% 15.04% 14.69% -

Items per share

        
Cash flow per share 1 3.598 2.366 2.677 3.411 4.602 3.927 4.559 5.63
Change - -34.24% 13.14% 27.41% 34.92% -14.66% 16.1% 23.5%
Dividend per Share 1 0.43 0.5 0.55 0.61 - 0.7492 0.8282 0.9075
Change - 16.28% 10% 10.91% - - 10.55% 9.58%
Book Value Per Share 1 10.04 10.37 9.864 13.68 14.43 17.67 21.73 28.36
Change - 3.35% -4.89% 38.71% 5.49% 22.45% 22.96% 30.53%
EPS 1 1.91 1.88 3.41 2.85 3.13 3.548 3.92 4.441
Change - -1.57% 81.38% -16.42% 9.82% 13.35% 10.49% 13.28%
Nbr of stocks (in thousands) 188,060 183,258 181,412 176,361 172,414 169,507 169,507 169,507
Announcement Date 2/11/22 2/9/23 2/8/24 2/6/25 2/5/26 - - -
1USD
Estimates
2026 *2027 *
P/E 8.35x 7.56x
PBR 1.68x 1.36x
EV / Sales 0.96x 0.77x
Yield 2.53% 2.79%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
29.64USD
Average target price
41.36USD
Spread / Average Target
+39.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. G Stock
  4. Financials Genpact Limited